Grail
Grail develops a pan-cancer screening test designed to detect cancers at an early stage.
| Company Details | |
|---|---|
| Title | Grail |
| Industries | Biotechnology, Health Care, Health Diagnostics, Medical, Medical Device |
| Headquarters Regions | San Francisco Bay Area, Silicon Valley, West Coast |
| Headquarters Location | Menlo Park, California, United States |
| No Of Employees | 501-1000 |
| Operating Status | Active |
Description
Grail develops a pan-cancer screening test designed to detect cancers at an early stage. Its pan-cancer screening test measures circulating nucleic acids in blood using high-intensity sequencing, population-scale clinical trials, enabling doctors to develop blood tests for early-stage cancer detection. The company was founded in 2016 by Alex Aravanis and Jeff Huber in Menlo Park, California.